Swedbank’s Medpace MEDP Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2026
Q2
$5.56M Sell
10,500
-1,500
-13% -$692K ﹤0.01% 576
2026
Q1
$5.76M Sell
12,000
-10,000
-45% -$5.12M 0.01% 556
2025
Q4
$12.4M Sell
22,000
-36,000
-62% -$20.4M 0.01% 467
2025
Q3
$29.8M Sell
58,000
-13,000
-18% -$5.68M 0.03% 306
2025
Q2
$22.3M Buy
71,000
+3,000
+4% +$901K 0.03% 345
2025
Q1
$20.7M Sell
68,000
-9,400
-12% -$3.16M 0.03% 344
2024
Q4
$25.7M Buy
77,400
+55,000
+246% +$18.7M 0.03% 304
2024
Q3
$7.48M Buy
+22,400
New +$8.51M 0.01% 489

Other funds holding MEDP

Swedbank's MEDP Position: Q2 2026 in Review

Swedbank reduced its Medpace (MEDP) stake by 13% in Q2 2026, selling an estimated $692K and leaving 10,500 shares worth $5.56M. The position accounts for ﹤0.01% of the portfolio, ranked #576.

Swedbank first reported a position in MEDP in Q3 2024 and has held it in 8 quarters since. The position peaked at $29.8M in Q3 2025. 697 funds tracked by Wall St. Rank hold MEDP as of Q2 2026.

  • Swedbank held 10,500 shares of Medpace worth $5.56M as of Q2 2026.
  • Swedbank sold 1,500 Medpace shares in Q2 2026, an estimated $692K.
  • Medpace made up ﹤0.01% of Swedbank's portfolio in Q2 2026, its #576 holding.
  • Swedbank first reported a position in Medpace in Q3 2024 and has held it in 8 quarters since.
  • Swedbank's Medpace position peaked at $29.8M in Q3 2025.
  • 697 funds tracked by Wall St. Rank held Medpace as of Q2 2026.

Based on Swedbank's 13F filing for Q2 2026, filed 15 Jul 2026.